2-Hydroxymethyl-5-(6-methylsulfanyl-purin-9-yl)-tetrahydro-furan-3,4-diol

ID: ALA2093901

Cas Number: 13153-62-3

PubChem CID: 40578255

Max Phase: Preclinical

Molecular Formula: C11H14N4O4S

Molecular Weight: 298.32

Molecule Type: Small molecule

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  CSc1ncnc2c1ncn2[C@@H]1O[C@H](CO)[C@@H](O)[C@@H]1O

Standard InChI:  InChI=1S/C11H14N4O4S/c1-20-10-6-9(12-3-13-10)15(4-14-6)11-8(18)7(17)5(2-16)19-11/h3-5,7-8,11,16-18H,2H2,1H3/t5-,7-,8+,11-/m1/s1

Standard InChI Key:  ZDRFDHHANOYUTE-ICQCTTRCSA-N

Molfile:  

     RDKit          2D

 20 22  0  0  0  0  0  0  0  0999 V2000
    9.1008   -7.5021    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    9.1008   -8.5698    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.4328   -7.0112    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.7011   -6.2233    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.5232   -6.2233    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    8.7754   -9.2549    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.7859   -7.0112    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.2215   -8.0731    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    7.6620   -9.2549    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.3195   -8.5698    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.1530   -5.6067    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.6278   -7.1767    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    7.3366   -5.7722    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    7.0797   -6.5601    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.2036   -9.9401    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    8.4157   -4.8188    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    7.2167   -9.9572    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    7.3195   -7.9190    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.7827   -7.7419    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    9.2207   -4.6646    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  2  1  1  1
  3  1  1  0
  4  3  2  0
  5  7  2  0
  6  2  1  0
  7  1  1  0
  8  2  1  0
  9  6  1  0
 10  8  1  0
 11  4  1  0
 12  3  1  0
 13 14  1  0
 14 12  2  0
  6 15  1  1
 16 11  1  0
  9 17  1  6
 10 18  1  1
 19 18  1  0
 20 16  1  0
  5  4  1  0
  9 10  1  0
 11 13  2  0
M  END

Associated Targets(non-human)

Eimeria tenella (990 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Biocomponents

Calculated Properties

Molecular Weight: 298.32Molecular Weight (Monoisotopic): 298.0736AlogP: -0.84#Rotatable Bonds: 3
Polar Surface Area: 113.52Molecular Species: NEUTRALHBA: 9HBD: 3
#RO5 Violations: HBA (Lipinski): 8HBD (Lipinski): 3#RO5 Violations (Lipinski):
CX Acidic pKa: 12.45CX Basic pKa: 3.31CX LogP: -0.63CX LogD: -0.63
Aromatic Rings: 2Heavy Atoms: 20QED Weighted: 0.50Np Likeness Score: 0.75

References

1. Lin TS, Cheng JC, Ishiguro K, Sartorelli AC..  (1985)  Purine and 8-substituted purine arabinofuranosyl and ribofuranosyl nucleoside derivatives as potential inducers of the differentiation of the Friend erythroleukemia.,  28  (10): [PMID:3862866] [10.1021/jm00148a018]
2. Krenitsky TA, Rideout JL, Koszalka GW, Inmon RB, Chao EY, Elion GB, Latter VS, Williams RB..  (1982)  Pyrazolo[3,4-d]pyrimidine ribonucleosides as anticoccidials. 1. Synthesis and activity of some nucleosides of purines and 4-(alkylthio)pyrazolo[3,4-d]pyrimidines.,  25  (1): [PMID:7086819] [10.1021/jm00343a007]

Source